|
CCDC117 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.233700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.074200E-02 |
| Normal-vs-Stage2 |
8.946400E-01 |
| Normal-vs-Stage3 |
9.954200E-01 |
| Normal-vs-Stage4 |
5.815000E-01 |
| Stage1-vs-Stage2 |
2.045000E-01 |
| Stage1-vs-Stage3 |
1.959410E-01 |
| Stage1-vs-Stage4 |
7.283800E-01 |
| Stage2-vs-Stage3 |
9.173200E-01 |
| Stage2-vs-Stage4 |
5.724600E-01 |
| Stage3-vs-Stage4 |
6.517600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.669500E-02 |
| Normal-vs-AfricanAmerican |
2.207200E-01 |
| Normal-vs-Asian |
1.036010E-01 |
| Caucasian-vs-AfricanAmerican |
8.954600E-01 |
| Caucasian-vs-Asian |
6.710200E-01 |
| AfricanAmerican-vs-Asian |
6.005200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.134100E-02 |
| Normal-vs-Female |
5.544000E-01 |
| Male-vs-Female |
4.275400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.099700E-03 |
| Normal-vs-Extreme_Weight |
4.062200E-02 |
| Normal-vs-Obese |
9.578400E-01 |
| Normal-vs-Extreme_Obese |
2.304400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.086200E-01 |
| Normal_Weight-vs-Obese |
1.779520E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.637600E-01 |
| Extreme_Weight-vs-Obese |
1.093150E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.595800E-01 |
| Obese-vs-Extreme_Obese |
3.841600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.620600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.432000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.072190E-02 |
| Normal-vs-Age(81-100Yrs) |
1.58218999999349E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.515600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.393900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.095600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.954100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.338900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.447700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.899800E-01 |
| Normal-VS-Type2 PRCC |
7.57780000000263E-05 |
| Normal-VS-KIRP CIMP |
9.084200E-02 |
| Normal-VS-Unclassified PRCC |
5.125000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.826000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.549630E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.154200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.824100E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.742300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.791600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.135900E-02 |
| Normal-vs-N1 |
2.563200E-01 |
| Normal-vs-N2 |
2.683800E-01 |
| N0-vs-N1 |
3.131800E-02 |
| N0-vs-N2 |
9.246600E-01 |
| N1-vs-N2 |
3.648200E-01 |
|
|
